SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility driven by a massive market sell-off in South Korea, fueled by concerns over leveraged ETF unwinding and institutional rebalancing. Community members are actively debating the sustainability of the memory sector boom, with many viewing the sharp price swings as an opportunity for tactical accumulation ahead of major upcoming events like the SK Hynix IPO.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing heightened community activity following institutional ownership filings and an annual meeting where management emphasized production scaling to meet AI infrastructure demand. While some investors remain cautious about execution timelines and recent price volatility, others are focused on the company's shift toward high-volume manufacturing and its potential to alleviate industry-wide data center bottlenecks.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is rallying on strong demand for AI infrastructure and memory systems, fueled by its role as an NVIDIA AI Factory partner and record quarterly sales. While bulls celebrate the company's position in the AI hardware supply chain, the stock is also seeing high volatility as traders debate whether it is a long-term growth play or an overextended trade prone to a pullback.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is experiencing high volatility as investors rotate capital amid concerns regarding elevated sector valuations and shifting AI demand outlooks. The community is actively debating the sustainability of AI capital expenditures, with significant attention on upcoming earnings reports and recent global market signals to determine if this marks a healthy consolidation or a deeper trend reversal.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as the community debates its commercialization timeline, with heightened interest surrounding the upcoming Ducati World Week showcase and the company's strategic move into power systems for AI data centers. Investors remain polarized, with many waiting for manufacturing scale-up news on the Eagle line while others express frustration over the lack of revenue and persistent short interest.

Roundhill ETF Trust - Roundhill Memory ETF

The DRAM ETF is trending as investors digest a memory sector sell-off, with the community closely tracking the upcoming U.S. Nasdaq listing of SK Hynix and strong Korean memory demand as potential catalysts for a rebound. Discussion is currently polarized, pitting bargain-hunting investors who view recent price drops as a healthy reset against bearish voices concerned about cyclical volatility and over-leveraged market dynamics.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is facing significant volatility as investors aggressively unwind overcrowded AI semiconductor positions, following regulatory scrutiny over high-leverage products and broader macro concerns. The market is actively debating whether this pullback represents a fundamental shift or a temporary consolidation for the sector's dominant memory giants.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is seeing intense investor focus as it hits all-time highs, driven by its essential role in providing the networking backbone for massive AI data center buildouts. The community is actively debating whether its recent momentum can be sustained toward higher price targets or if a short-term pullback is imminent amid high volatility in the AI infrastructure sector.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors remain focused on commercial execution and the potential for long-term profitability, despite ongoing volatility and concerns regarding management's capital allocation. The community is actively debating the impact of the final legal resolution on product reimbursement, while weighing whether current price action represents a buying opportunity or a signal of deeper institutional skepticism.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest unprecedented Phase 3 data for daraxonrasib in pancreatic cancer, which demonstrated a significant survival benefit and reduction in death risk compared to standard chemotherapy. Community discussion remains intensely focused on the stock's potential as a major acquisition target, with active debates centered on whether the company should pursue an independent path to commercialization or accept a potential buyout from large pharmaceutical players.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

HHHooper Holmes Inc.

Latest HH News